Neuroscientific Biopharmaceuticals Ltd (NSB) — Cash Flow Quality Index

Latest as of June 2024: 1.04x

Neuroscientific Biopharmaceuticals Ltd (NSB) has a Cash Flow Quality Index of 1.04x as of June 2024. Operating cash flow of AU$1.62 Million exceeds net income of AU$1.55 Million, indicating high earnings quality where cash backs reported profits. Explore NSB operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

1.04x
Operating CF / Net Income

Operating Cash Flow

AU$1.62 Million
AUD

Net Income

AU$1.55 Million
AUD

Data as of

Jun 2024
Most recent filing

Neuroscientific Biopharmaceuticals Ltd Cash Flow Quality Index (2024–2024)

Historical Cash Flow Quality Index for Neuroscientific Biopharmaceuticals Ltd across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Neuroscientific Biopharmaceuticals Ltd operating cash flow efficiency.

Annual Cash Flow Quality Index for Neuroscientific Biopharmaceuticals Ltd (2024–2024)

Year-by-year earnings quality comparison for Neuroscientific Biopharmaceuticals Ltd.

Year Quality Index Operating CF (AUD) Net Income YoY Change
2024 0.14x AU$44.25K AU$324.21K —
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.